RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
6.57
+0.31 (4.95%)
At close: Aug 10, 2026, 4:00 PM EDT
6.58
+0.01 (0.15%)
After-hours: Aug 10, 2026, 7:34 PM EDT
RxSight Employees
RxSight had 461 employees as of December 31, 2025. The number of employees decreased by 37 or -7.43% compared to the previous year.
Employees
461
Change (1Y)
-37
Growth (1Y)
-7.43%
Revenue / Employee
$276,751
Profits / Employee
-$101,842
Market Cap
273.27M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 461 | -37 | -7.43% |
| Dec 31, 2024 | 498 | 124 | 33.16% |
| Dec 31, 2023 | 374 | 82 | 28.08% |
| Dec 31, 2022 | 292 | 71 | 32.13% |
| Dec 31, 2021 | 221 | 50 | 29.24% |
| Mar 31, 2021 | 171 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| InfuSystem Holdings | 473 |
| Treace Medical Concepts | 450 |
| Quanterix | 450 |
| Standard BioTools | 389 |
| AVITA Medical | 226 |
| Electromed | 180 |
| 908 Devices | 172 |
| Perspective Therapeutics | 166 |
RXST News
- 19 hours ago - RxSight price target lowered to $7 from $8 at Stifel - TheFly
- 4 days ago - RxSight price target raised to $6.30 from $5.50 at UBS - TheFly
- 4 days ago - RxSight says withdrawing guidance, will resume formal guidance in 2027 - TheFly
- 5 days ago - RxSight reports Q2 adjusted EPS (11c), consensus (19c) - TheFly
- 5 days ago - RxSight Earnings Call Transcript: Q2 2026 - Transcripts
- 5 days ago - RxSight Earnings release: Q2 2026 - Filings
- 5 days ago - RxSight Quarterly report: Q2 2026 - Filings
- 5 days ago - RxSight, Inc. Reports Second Quarter 2026 Results and Provides Update on 2026 Outlook - GlobeNewsWire